Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
AC Immune is a Switzerland-based biopharmaceutical company specializing in the development of innovative therapies and diagnostics for neurodegenerative diseases. It focuses on precision medicine to treat Alzheimer’s and other proteinopathies, advancing targeted solutions for these complex conditions.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
AC Immune is scheduled to report its next quarterly earnings on 11/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
AC Immune last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 0.02 USD.
Across its last 3 earnings reports, AC Immune stock moved by ±1.6% on average the following day. The largest reaction was +3.4% on 04/30/2026; 3 of 3 reactions were positive.
AC Immune has beaten analyst EPS estimates in 4 of its last 5 evaluated quarters (beat rate: 80%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.